A Retrospective Study of Endoscopic Resection for 368 Patients with Early Esophageal Squamous Cell Carcinoma or Precancerous Lesions

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2016 Nov 13

PMID 27837320

Citations 13

Authors

Dongxian Jiang

Xuquan Li

Haixing Wang

Chen Xu

Xiaojing Li

Akesu Sujie

Haiying Zeng

Yingyong Hou

Yunshi Zhong

Affiliations

Soon will be listed here.

Abstract

Background: To retrospectively investigate the clinicopathological features and prognosis of early esophageal squamous cell neoplasm (ESCN) treated with endoscopic resection (ER), especially, to compare the prognosis in patients with sm2 cancer and non-sm2 cancer.

Methods: From 2007 to 2013, 368 patients were included in our analysis.

Results: The patients were 252 (68.5 %) men and 116 (31.5 %) women with a median age of 61 (range 16-84 years) years. Hyperplasia, mild dysplasia, moderate dysplasia, severe dysplasia, m1, m2, m3, sm1, and sm2 were diagnosed in 47 (12.8 %), 27 (7.3 %), 34 (9.2 %), 61 (16.6 %), 54 (14.7 %), 38 (10.3 %), 63 (17.1 %), 12 (3.3 %), and 32 (8.7 %) cases. The mean (range) follow-up time was 29 (0-84) months. The cumulative overall 1-, 3-, and 5-year metachronous esophageal lesion rates were 4.1, 12.9, and 32.6 %. The incidence of lymph node or distant metastasis was 1.54 % in m3, 6.25 % in sm2, and 0 in other subgroups. The overall 1-, 3-, and 5-year survival rates were 99.5, 97.3, and 87.5 %. There was significant difference between sm2 and non-sm2 patients in metastatic rate (P = 0.021); however, no difference existed between m3 patients and sm2 patients (P = 0.252). The difference of metachronous esophageal lesion (P = 0.401) and survival (P = 0.634) between sm2 and non-sm2 patients was not obvious.

Conclusions: Our study showed that ER was an effective and relatively safe treatment for superficial ESCN. ER is still appropriate in select sm2 patients. To monitor the second primary cancer in sm2 is necessary during the follow-up.

Citing Articles

Intratumoral microbiota: a new force in the development and treatment of esophageal cancer.

Jing T, Tang D Clin Transl Oncol. 2024; .

PMID: 39455494 DOI: 10.1007/s12094-024-03757-1.

Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression.

Li L, Jiang D, Liu H, Guo C, Zhang Q, Li X Cancer Res. 2024; 84(17):2888-2910.

PMID: 38861363 PMC: 11372369. DOI: 10.1158/0008-5472.CAN-23-1878.

Surveillance for metachronous cancers after endoscopic resection of esophageal squamous cell carcinoma.

Ishihara R Clin Endosc. 2024; 57(5):559-570.

PMID: 38725400 PMC: 11474468. DOI: 10.5946/ce.2023.263.

Novel milestones for early esophageal carcinoma: From bench to bed.

Qi J, Huang S, Jin S World J Gastrointest Oncol. 2024; 16(4):1104-1118.

PMID: 38660637 PMC: 11037034. DOI: 10.4251/wjgo.v16.i4.1104.

A practical nomogram included hyperlipidemia for predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.

Wang J, Liu X, Mao T, Xu Z, Li H, Li X Medicine (Baltimore). 2023; 102(46):e35891.

PMID: 37986324 PMC: 10659609. DOI: 10.1097/MD.0000000000035891.

References

Yamada M, Oda I, Nonaka S, Suzuki H, Yoshinaga S, Taniguchi H . Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy. 2013; 45(12):992-6. DOI: 10.1055/s-0033-1344862. View

Zhai Y, Linghu E, Li H . Double-tunnel endoscopic submucosal tunnel dissection for circumferential superficial esophageal neoplasms. Endoscopy. 2014; 46 Suppl 1 UCTN:E204-5. DOI: 10.1055/s-0034-1365390. View

Higuchi K, Tanabe S, Koizumi W, Sasaki T, Nakatani K, Saigenji K . Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma. Endoscopy. 2007; 39(1):36-40. DOI: 10.1055/s-2006-945148. View

Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M . Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005; 3(7 Suppl 1):S67-70. DOI: 10.1016/s1542-3565(05)00291-0. View

Manner H, May A, Pech O, Gossner L, Rabenstein T, Gunter E . Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008; 103(10):2589-97. DOI: 10.1111/j.1572-0241.2008.02083.x. View

Arnold M, Soerjomataram I, Ferlay J, Forman D . Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014; 64(3):381-7. DOI: 10.1136/gutjnl-2014-308124. View

Schlemper R, Dawsey S, Itabashi M, Iwashita A, Kato Y, Koike M . Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer. 2000; 88(5):996-1006. DOI: 10.1002/(sici)1097-0142(20000301)88:5<996::aid-cncr8>3.0.co;2-q. View

Badreddine R, Prasad G, Lewis J, Lutzke L, Borkenhagen L, Dunagan K . Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol. 2009; 8(3):248-53. PMC: 2834861. DOI: 10.1016/j.cgh.2009.11.016. View

Joo D, Kim G, Park D, Jhi J, Song G . Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver. 2014; 8(6):612-8. PMC: 4215446. DOI: 10.5009/gnl13130. View

10.

Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M . Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2013; 146(3):652-660.e1. DOI: 10.1053/j.gastro.2013.11.006. View

11.

Crumley A, Going J, McEwan K, McKernan M, Abela J, Shearer C . Endoscopic mucosal resection for gastroesophageal cancer in a U.K. population. Long-term follow-up of a consecutive series. Surg Endosc. 2010; 25(2):543-8. DOI: 10.1007/s00464-010-1213-9. View

12.

Merkow R, Bilimoria K, Keswani R, Chung J, Sherman K, Knab L . Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014; 106(7). DOI: 10.1093/jnci/dju133. View

13.

Takekoshi T, Baba Y, Ota H, Kato Y, Yanagisawa A, Takagi K . Endoscopic resection of early gastric carcinoma: results of a retrospective analysis of 308 cases. Endoscopy. 1994; 26(4):352-8. DOI: 10.1055/s-2007-1008990. View

14.

Higuchi K, Tanabe S, Azuma M, Katada C, Sasaki T, Ishido K . A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901). Gastrointest Endosc. 2013; 78(5):704-10. DOI: 10.1016/j.gie.2013.04.182. View

15.

Bhatt A, Abe S, Kumaravel A, Vargo J, Saito Y . Indications and Techniques for Endoscopic Submucosal Dissection. Am J Gastroenterol. 2015; 110(6):784-91. DOI: 10.1038/ajg.2014.425. View

16.

Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K . Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004; 127(2):385-94. DOI: 10.1053/j.gastro.2004.04.022. View

17.

Yano T, Ono H, Doi T, Hasegawa H, Honda M, Oono Y . Endoscopic submucosal dissection using a new scissors-type electrosurgical knife: a first-in-human feasibility study. Endoscopy. 2014; 46(9):754-7. DOI: 10.1055/s-0034-1365473. View

18.

Deyhle P, Jenny S, Fumagalli I . [Endoscopic polypectomy in the proximal colon. A diagnostic, therapeutic (and preventive?) intervention]. Dtsch Med Wochenschr. 1973; 98(5):219-20. DOI: 10.1055/s-0028-1106782. View

19.

Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N . Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009; 70(5):860-6. DOI: 10.1016/j.gie.2009.04.044. View

20.

Tsujii Y, Nishida T, Nishiyama O, Yamamoto K, Kawai N, Yamaguchi S . Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy. 2015; 47(9):775-83. DOI: 10.1055/s-0034-1391844. View